Latest Whitepapers

In this paper, we demonstrate how the GeneArt Gibson Assembly HiFi Cloning Kit can be used with multiple Invitrogen™ GeneArt™ Strings DNA Fragments to produce large constructs in highly efficient reactions.

This whitepaper explores the advantages of a novel cell sorting and dispensing platform – which combines microfluidics, flow cytometry and liquid dispensing – that can help researchers get to their optimal clones more efficiently.

Understanding the mechanisms of human disease requires a multiomic approach; however, legacy multiomic methods require multiple platforms and complex processes with lengthy turnaround times and considerable costs.

This article explores major advances in disease modification for illnesses that still lack effective treatments, as well as some challenges and approaches to overcome them.

These advances owe much to increased raw sequencing power and ever-more ingenious techniques for sampling genomic data, but these advances would be for naught if we weren’t able to process and analyze the data torrent that pours from these sequencing projects.

Single-use fermenters (SUFs) use disposable sterile plastic bags that don’t require the traditional high-intensity preparation of SS bioreactors, which are expensive and time-consuming processes.

Tissue dissociation is a crucial sample preparation step that enables the isolation of specific cell populations for downstream applications such as single-cell RNA sequencing. Enzymatic tissue dissociation is widely used, but some researchers have concerns about the impact of enzymes on cell marker expression.

This whitepaper explores the latest reagents and software available to enhance tumor exome profiling for the generation of accurate, actionable clinical insights.

The rapid and accurate identification of microbial contaminants is crucial for quality control in pharmaceutical processes and products. However, until recently, testing labs have relied on time-consuming phenotypic approaches.

Developing mRNA-based therapeutics is complex work, requiring highly skilled scientists, high-tech microfluidics platforms and sophisticated analytical equipment, and of course the mRNA itself.